EMEA-002248-PIP01-17

Key facts

Active substance
  • candesartan (cilexetil)
  • Amlodipine (besylate)
Therapeutic area
Cardiovascular diseases
Decision number
P/0093/2018
PIP number
EMEA-002248-PIP01-17
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Midas Pharma GmbH

E-mail: ra@midas-pharma.com
Tel. +49 6132 9900

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating